Moleculin Biotech

MBRX

Börsenwert 8,26 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Vanguard Group Malvern, Pennsylvania	1,56 Mio. $	–	–	–
2	2 Sio Capital Management New York	1,5 Mio. $	-11.636 $	-1	-0,7 %
3	3 BlackRock New York	384.000 $	–	–	–
4	4 Geode Capital Management Boston, Massachusetts	358.000 $	–	–	–
5	5 Renaissance Technologies New York	128.000 $	+46.544 $	+4	+50 %
6	6 State Street Boston, Massachusetts	104.000 $	–	–	–
7	7 Sigma Planning Corp Ann Arbor, Michigan	83.000 $	–	–	–
8	8 Northern Trust Chicago, Illinois	67.000 $	-11.636 $	-1	-14 %
9	9 Charles Schwab San Francisco, California	46.000 $	+11.636 $	+1	+33 %
10	10 JMAC Enterprises Newtown, Pennsylvania	19.000 $	+23.272 $	+2	Neu
11	11 Two Sigma Advisers New York	17.000 $	-11.636 $	-1	-33 %
12	12 Bank of America Charlotte, North Carolina	10.000 $	–	–	–
13	13 Morgan Stanley New York	9.000 $	–	–	–
14	14 Osaic Holdings Scottsdale, Arizona	6.000 $	–	–	–
15	15 Tower Research Capital (TRC) New York	6.000 $	–	–	–
16	16 Urban Wealth Management El Segundo, California	4.000 $	–	–	–
17	17 Rockefeller Capital Management New York	2.000 $	–	–	–
18	18 UBS Group Zurich, Switzerland	2.000 $	–	–	–
19	19 CAPTRUST Financial Advisors Raleigh, North Carolina	1.000 $	–	–	–
20	20 CVA Family Office Denver, Colorado	1.000 $	–	–	–
21	APA 21 American Portfolios Advisors Holbrook, New York	484 $	–	–	–
22	22 Fidelity Investments Boston, Massachusetts	25 $	–	–	–
23	23 Envestnet Asset Management Chicago, Illinois	–	-19.000 $	-1	Geschlossen
24	24 Wells Fargo San Francisco, California	–	-11.636 $	-1	Geschlossen
25	25 JP Morgan Chase New York	–	-1.000 $	–	–

Moleculin Biotech MBRX Börsenwert 8,26 Mio. $

Moleculin Biotech

MBRX

Börsenwert 8,26 Mio. $